Medical - Diagnostics & Research
Compare Stocks
2 / 10Stock Comparison
A vs DHR
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Diagnostics & Research
A vs DHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Diagnostics & Research | Medical - Diagnostics & Research |
| Market Cap | $33.31B | $123.80B |
| Revenue (TTM) | $7.07B | $24.78B |
| Net Income (TTM) | $1.29B | $3.69B |
| Gross Margin | 38.8% | 60.7% |
| Operating Margin | 20.6% | 21.0% |
| Forward P/E | 19.7x | 20.7x |
| Total Debt | $3.35B | $18.42B |
| Cash & Equiv. | $1.79B | $4.62B |
A vs DHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Agilent Technologie… (A) | 100 | 133.5 | +33.5% |
| Danaher Corporation (DHR) | 100 | 118.4 | +18.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: A vs DHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
A carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 10 yrs, beta 1.23, yield 0.8%
- Rev growth 6.7%, EPS growth 3.2%, 3Y rev CAGR 0.5%
- PEG 1.34 vs DHR's 34.20
DHR is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 218.0% 10Y total return vs A's 202.6%
- Lower volatility, beta 0.94, Low D/E 35.1%, current ratio 1.87x
- Beta 0.94 vs A's 1.23, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.7% revenue growth vs DHR's 2.9% | |
| Value | Lower P/E (19.7x vs 20.7x), PEG 1.34 vs 34.20 | |
| Quality / Margins | 18.3% margin vs DHR's 14.9% | |
| Stability / Safety | Beta 0.94 vs A's 1.23, lower leverage | |
| Dividends | 0.8% yield, 10-year raise streak, vs DHR's 0.7% | |
| Momentum (1Y) | +12.8% vs DHR's -7.2% | |
| Efficiency (ROA) | 10.1% ROA vs DHR's 4.5%, ROIC 13.5% vs 5.9% |
A vs DHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
A vs DHR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DHR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DHR is the larger business by revenue, generating $24.8B annually — 3.5x A's $7.1B. Profitability is closely matched — net margins range from 18.3% (A) to 14.9% (DHR). On growth, A holds the edge at +7.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $7.1B | $24.8B |
| EBITDAEarnings before interest/tax | $1.7B | $7.2B |
| Net IncomeAfter-tax profit | $1.3B | $3.7B |
| Free Cash FlowCash after capex | $993M | $5.3B |
| Gross MarginGross profit ÷ Revenue | +38.8% | +60.7% |
| Operating MarginEBIT ÷ Revenue | +20.6% | +21.0% |
| Net MarginNet income ÷ Revenue | +18.3% | +14.9% |
| FCF MarginFCF ÷ Revenue | +14.1% | +21.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.0% | +3.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.6% | +9.8% |
Valuation Metrics
A leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 25.8x trailing earnings, A trades at a 26% valuation discount to DHR's 34.7x P/E. Adjusting for growth (PEG ratio), A offers better value at 1.75x vs DHR's 34.20x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $33.3B | $123.8B |
| Enterprise ValueMkt cap + debt − cash | $34.9B | $137.6B |
| Trailing P/EPrice ÷ TTM EPS | 25.75x | 34.71x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.71x | 20.73x |
| PEG RatioP/E ÷ EPS growth rate | 1.75x | 34.20x |
| EV / EBITDAEnterprise value multiple | 19.74x | 18.14x |
| Price / SalesMarket cap ÷ Revenue | 4.79x | 5.04x |
| Price / BookPrice ÷ Book value/share | 4.96x | 2.37x |
| Price / FCFMarket cap ÷ FCF | 28.92x | 23.54x |
Profitability & Efficiency
A leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
A delivers a 18.7% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $7 for DHR. DHR carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to A's 0.50x. On the Piotroski fundamental quality scale (0–9), DHR scores 7/9 vs A's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +18.7% | +7.1% |
| ROA (TTM)Return on assets | +10.1% | +4.5% |
| ROICReturn on invested capital | +13.5% | +5.9% |
| ROCEReturn on capital employed | +14.5% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.50x | 0.35x |
| Net DebtTotal debt minus cash | $1.6B | $13.8B |
| Cash & Equiv.Liquid assets | $1.8B | $4.6B |
| Total DebtShort + long-term debt | $3.4B | $18.4B |
| Interest CoverageEBIT ÷ Interest expense | 19.53x | 18.13x |
Total Returns (Dividends Reinvested)
A leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in A five years ago would be worth $9,234 today (with dividends reinvested), compared to $7,907 for DHR. Over the past 12 months, A leads with a +12.8% total return vs DHR's -7.2%. The 3-year compound annual growth rate (CAGR) favors A at -3.1% vs DHR's -5.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -14.3% | -23.9% |
| 1-Year ReturnPast 12 months | +12.8% | -7.2% |
| 3-Year ReturnCumulative with dividends | -9.0% | -15.9% |
| 5-Year ReturnCumulative with dividends | -7.7% | -20.9% |
| 10-Year ReturnCumulative with dividends | +202.6% | +218.0% |
| CAGR (3Y)Annualised 3-year return | -3.1% | -5.6% |
Risk & Volatility
Evenly matched — A and DHR each lead in 1 of 2 comparable metrics.
Risk & Volatility
DHR is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than A's 1.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.23x | 0.94x |
| 52-Week HighHighest price in past year | $160.27 | $242.80 |
| 52-Week LowLowest price in past year | $104.36 | $172.06 |
| % of 52W HighCurrent price vs 52-week peak | +73.4% | +72.0% |
| RSI (14)Momentum oscillator 0–100 | 52.2 | 32.3 |
| Avg Volume (50D)Average daily shares traded | 2.0M | 4.1M |
Analyst Outlook
A leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates A as "Buy" and DHR as "Buy". Consensus price targets imply 41.2% upside for DHR (target: $247) vs 41.0% for A (target: $166). For income investors, A offers the higher dividend yield at 0.84% vs DHR's 0.71%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $166.00 | $247.00 |
| # AnalystsCovering analysts | 38 | 42 |
| Dividend YieldAnnual dividend ÷ price | +0.8% | +0.7% |
| Dividend StreakConsecutive years of raises | 10 | 1 |
| Dividend / ShareAnnual DPS | $0.99 | $1.23 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.3% | +2.5% |
A leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). DHR leads in 1 (Income & Cash Flow). 1 tied.
A vs DHR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is A or DHR a better buy right now?
For growth investors, Agilent Technologies, Inc.
(A) is the stronger pick with 6. 7% revenue growth year-over-year, versus 2. 9% for Danaher Corporation (DHR). Agilent Technologies, Inc. (A) offers the better valuation at 25. 8x trailing P/E (19. 7x forward), making it the more compelling value choice. Analysts rate Agilent Technologies, Inc. (A) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — A or DHR?
On trailing P/E, Agilent Technologies, Inc.
(A) is the cheapest at 25. 8x versus Danaher Corporation at 34. 7x. On forward P/E, Agilent Technologies, Inc. is actually cheaper at 19. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Agilent Technologies, Inc. wins at 1. 34x versus Danaher Corporation's 34. 20x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — A or DHR?
Over the past 5 years, Agilent Technologies, Inc.
(A) delivered a total return of -7. 7%, compared to -20. 9% for Danaher Corporation (DHR). Over 10 years, the gap is even starker: DHR returned +218. 0% versus A's +202. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — A or DHR?
By beta (market sensitivity over 5 years), Danaher Corporation (DHR) is the lower-risk stock at 0.
94β versus Agilent Technologies, Inc. 's 1. 23β — meaning A is approximately 31% more volatile than DHR relative to the S&P 500. On balance sheet safety, Danaher Corporation (DHR) carries a lower debt/equity ratio of 35% versus 50% for Agilent Technologies, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — A or DHR?
By revenue growth (latest reported year), Agilent Technologies, Inc.
(A) is pulling ahead at 6. 7% versus 2. 9% for Danaher Corporation (DHR). On earnings-per-share growth, the picture is similar: Agilent Technologies, Inc. grew EPS 3. 2% year-over-year, compared to -4. 7% for Danaher Corporation. Over a 3-year CAGR, A leads at 0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — A or DHR?
Agilent Technologies, Inc.
(A) is the more profitable company, earning 18. 8% net margin versus 14. 7% for Danaher Corporation — meaning it keeps 18. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: A leads at 21. 3% versus 20. 9% for DHR. At the gross margin level — before operating expenses — DHR leads at 60. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is A or DHR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Agilent Technologies, Inc. (A) is the more undervalued stock at a PEG of 1. 34x versus Danaher Corporation's 34. 20x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Agilent Technologies, Inc. (A) trades at 19. 7x forward P/E versus 20. 7x for Danaher Corporation — 1. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHR: 41. 2% to $247. 00.
08Which pays a better dividend — A or DHR?
All stocks in this comparison pay dividends.
Agilent Technologies, Inc. (A) offers the highest yield at 0. 8%, versus 0. 7% for Danaher Corporation (DHR).
09Is A or DHR better for a retirement portfolio?
For long-horizon retirement investors, Danaher Corporation (DHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
94), 0. 7% yield, +218. 0% 10Y return). Both have compounded well over 10 years (DHR: +218. 0%, A: +202. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between A and DHR?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.